ENT Devices: Large Markets, Minimally Invasive Procedures Fuel Innovation
This article was originally published in Start Up
For innovators in the medical device industry, the otolaryngology or ENT (ear, nose, and throat) specialty offers just about everything that investors look for these days. Profiles of Aerin Medical, Spirox, Fiagon AG Medical, and ENTvantage Diagnostics.
You may also be interested in...
The device IPO class of 2014 gained on share price, with several outperforming by more than 100%, and market caps for larger companies have grown at a rapid pace.
Faced with the large unmet clinical need of people with chronic nasal obstruction, an ENT physician formed Spirox to develop a non-surgical implant to restore the nasal valve. The ultimate goal is to develop a 15-minute procedure that ENTs can perform in their office to help patients breathe better.
Sinusitis is one malady that is prone to antibiotic overuse - antibiotics are prescribed for some 50% of patients, partly because busy physicians don’t feel they have the time to explain to them why an antibiotic is not appropriate. ENTvantage Diagnostics Inc. is developing a point-of-care diagnostic to quickly determine whether patients have bacterial or viral sinusitis.